Beating both EPS and sales estimates typically signals operational efficiency and strong demand for a company's products or services. For PROCEPT BioRobotics, surpassing these estimates and showing significant year-over-year sales growth suggests a positive market reception and operational success, likely leading to increased investor confidence and potential stock price appreciation in the short term.